Biomedical Engineering Reference
In-Depth Information
N-oxides in intact human cells using 647-nmkrypton laser excitation. Cytometry 1997;27
(1):43-53.
129. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette
(ABC) family: an overview. Adv. Drug Deliv. Rev. 2003;55(1):3-29.
130. Ivnitski-Steele I, Larson RS, Lovato DM, Khawaja HM, Winter SS, Oprea TI, Sklar LA,
Edwards BS. High-throughput flow cytometry to detect selective inhibitors of ABCB1,
ABCC1, and ABCG2 transporters. Assay Drug Dev. Technol. 2008;6(2):263-276.
131. Demel MA, Schwaha R, Kramer O, Ettmayer P, Haaksma EE, Ecker GF. In silico
prediction of substrate properties for ABC-multidrug transporters. Expert Opin. Drug
Metab. Toxicol. 2008;4(9):1167-1180.
132. Winter SS, LovatoDM, KhawajaHM, Edwards BS, Steele ID, Young SM, Oprea TI, Sklar
LA, Larson RS. High-throughput screening for daunorubicin-mediated drug resistance
identifies mometasone furoate as a novel ABCB1-reversal agent. J. Biomol. Screen.
2008;13(3):185-193.
133. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells.
Nature 2001;414(6859):105-111.
134. Hart LS, El-Deiry WS. Invincible, but not invisible: imaging approaches toward in vivo
detection of cancer stem cells. J. Clin. Oncol. 2008;26(17):2901-2910.
135. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence
and unresolved questions. Nat. Rev. Cancer 2008;8(10):755-768.
136. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q,
Jordan S, Duncan LM, Weishaupt C, et al. Identification of cells initiating human
melanomas. Nature 2008;451(7176):345-349.
137. Goodell MA, McKinney-Freeman S, Camargo FD. Isolation and characterization of side
population cells. Methods Mol. Biol. 2005;290:343-352.
138. Hirschmann-Jax C, Foster AE, Wulf GG, Goodell MA, Brenner MK. A distinct “side
population” of cells in human tumor cells: implications for tumor biology and therapy.
Cell Cycle 2005;4(2):203-205.
139. Smith PJ, Nakeff A, Watson JV. Flow-cytometric detection of changes in the fluorescence
emission spectrum of a vital DNA-specific dye in human tumour cells. Exp. Cell Res.
1985;159(1):37-46.
140. Cabana R, Frolova EG, Kapoor V, Thomas RA, Krishan A, Telford WG. The minimal
instrumentation requirements for Hoechst side population analysis: stem cell analysis on
low-cost flow cytometry platforms. Stem Cells 2006;24(11):2573-2581.
141. TelfordWG, Bradford J, GodfreyW, Robey RW, Bates SE. Side population analysis using
a violet-excited cell-permeable DNA binding dye. Stem Cells 2007;25(4):1029-1036.
142. Hawley TS, TelfordWG, HawleyRG. “Rainbow” reporters for multispectral marking and
lineage analysis of hematopoietic stem cells. Stem Cells 2001;19(2):118-124.
143. Huuskonen H. New models and molecular markers in evaluation of developmental
toxicity. Toxicol. Appl. Pharmacol. 2005;207(2 Suppl.):495-500.
144. Buesen R, Genschow E, Slawik B, Visan A, Spielmann H, Luch A, Seiler A. Embryonic
stem cell test remastered: comparison between the validated EST and the new molecular
FACS-EST for assessing developmental
toxicity in vitro. Toxicol. Sci. 2009;108
(2):389-400.
145. Kenakin TP. Cellular assays as portals to seven-transmembrane receptor-based drug
discovery. Nat. Rev. Drug Discov. 2009;8(8):617-626.
Search WWH ::




Custom Search